title: Once-daily extended-release niacin lowers serum phosphorus concentrations in patients with metabolic syndrome dyslipidemia.
authors.forename: Susie
authors.initials: S
authors.lastname: Hu
authors.forename: Gregory C
authors.initials: GC
authors.lastname: Shearer
authors.forename: Michael W
authors.initials: MW
authors.lastname: Steffes
authors.forename: William S
authors.initials: WS
authors.lastname: Harris
authors.forename: Andrew G
authors.initials: AG
authors.lastname: Bostom
mesh_terms: D002118:Calcium / Q000097:blood; D003692:Delayed-Action Preparations; D004334:Drug Administration Schedule; D050171:Dyslipidemias / Q000097:blood / Q000188:drug therapy*; D005919:Glomerular Filtration Rate; D006801:Humans; D000960:Hypolipidemic Agents / Q000008:administration & dosage*; D024821:Metabolic Syndrome / Q000097:blood* / Q000503:physiopathology; D009525:Niacin / Q000008:administration & dosage*; D010758:Phosphorus / Q000097:blood*; D012709:Serum Albumin / Q000032:analysis
chemical_list: D003692:Delayed-Action Preparations; D000960:Hypolipidemic Agents; D012709:Serum Albumin; D009525:Niacin; D010758:Phosphorus; D002118:Calcium